Literature DB >> 23063761

A prospective study of quality of life in patients undergoing pelvic exenteration: interim results.

Youssef A Rezk1, Karen E Hurley, Jeanne Carter, Fanny Dao, Bernard H Bochner, Janice J Aubey, Aileen Caceres, M Heather Einstein, Nadeem R Abu-Rustum, Richard R Barakat, Vicky Makker, Dennis S Chi.   

Abstract

OBJECTIVE: Little prospective data exist on quality of life (QOL) after pelvic exenteration (PE). This ongoing study prospectively examines the QOL changes following this radical procedure using a comprehensive battery of psychological instruments.
METHODS: Since 2005, enrolled patients were interviewed (EORTC QLQ-C30, EORTC QLQ-CR38, EORTC QLQ-BLM30, BFI, BPI-SF, IADL, CES-D, IES-R) preoperatively and at 3, 6, and 12 months after PE for physical/psychological symptoms. Data were examined using repeated measure ANOVA.
RESULTS: Sixteen women (3 anterior, 1 posterior, and 12 total PEs), with more than 1 year of follow-up, completed all scheduled interviews. Median age was 58 years (range, 28-76 years). Overall QOL (F = 6.3, p < 0.02), ability to perform instrumental daily activities (F = 6.8, p < 0.02), body image (F = 11.9, p < 0.00), and sexual function (F = 8.0, p < 0.01) all declined at 3 months but were near baseline by 12 months after PE. Although, overall, physical function followed a similar trend (F = 14.8, p < 0.00), it did not return to baseline. At the 12-month interview, patients reported increased gastrointestinal symptoms (F = 8.9, p < 0.01) but significantly less stress-related ideation (F = 6.1, p < 0.03) compared to baseline. Pain levels did not change significantly during the study period (F = 0.4, p < 0.74).
CONCLUSIONS: Although patients report lingering gastrointestinal symptoms and some persistent decline in physical function after PE, most adjust well, returning to almost baseline functioning within a year. Providers can counsel patients that many, though not all, symptoms in the first 3 months following exenteration are likely to improve as they adapt to their changed health status. These preliminary results await confirmation of a larger analysis.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23063761      PMCID: PMC4174356          DOI: 10.1016/j.ygyno.2012.09.030

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  38 in total

1.  The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life.

Authors:  M A Sprangers; A te Velde; N K Aaronson
Journal:  Eur J Cancer       Date:  1999-02       Impact factor: 9.162

2.  Quality of life in patients with urinary diversion after operation for locally advanced rectal cancer.

Authors:  M G Guren; J N Wiig; S Dueland; K M Tveit; S D Fosså; H Waehre; K E Giercksky
Journal:  Eur J Surg Oncol       Date:  2001-11       Impact factor: 4.424

3.  Psychometric properties of the Impact of Event Scale amongst women at increased risk for hereditary breast cancer.

Authors:  B Thewes; B Meiser; I B Hickie
Journal:  Psychooncology       Date:  2001 Nov-Dec       Impact factor: 3.894

4.  Measurement of depressive symptoms in cancer patients: evaluation of the Center for Epidemiological Studies Depression Scale (CES-D).

Authors:  D Hann; K Winter; P Jacobsen
Journal:  J Psychosom Res       Date:  1999-05       Impact factor: 3.006

Review 5.  Development of a comprehensive quality of life measurement tool: CARES.

Authors:  C A Schag; R L Heinrich
Journal:  Oncology (Williston Park)       Date:  1990-05       Impact factor: 2.990

6.  Psychosexual adjustment following pelvic exenteration.

Authors:  B L Andersen; N F Hacker
Journal:  Obstet Gynecol       Date:  1983-03       Impact factor: 7.661

7.  Brief report: total pelvic exenteration--A retrospective clinical needs assessment.

Authors:  Jeanne Carter; Dennis S Chi; Nadeem Abu-Rustum; Carol L Brown; Wayne McCreath; Richard R Barakat
Journal:  Psychooncology       Date:  2004-02       Impact factor: 3.894

8.  Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire.

Authors:  M J Hjermstad; S D Fossa; K Bjordal; S Kaasa
Journal:  J Clin Oncol       Date:  1995-05       Impact factor: 44.544

9.  Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology.

Authors: 
Journal:  J Clin Oncol       Date:  1996-02       Impact factor: 44.544

10.  Surgical and psychosexual outcome following vaginal reconstruction with pelvic exenteration.

Authors:  N Gleeson; W Baile; W S Roberts; M Hoffman; J V Fiorica; D Barton; D Cavanagh
Journal:  Eur J Gynaecol Oncol       Date:  1994       Impact factor: 0.196

View more
  9 in total

Review 1.  Self-Reported Sexual Function Measures Administered to Female Cancer Patients: A Systematic Review, 2008-2014.

Authors:  Diana D Jeffery; Lisa Barbera; Barbara L Andersen; Amy K Siston; Anuja Jhingran; Shirley R Baron; Jennifer Barsky Reese; Deborah J Coady; Jeanne Carter; Kathryn E Flynn
Journal:  J Psychosoc Oncol       Date:  2015

2.  Initial experience of laparoscopic pelvic exenteration and comparison with conventional open surgery.

Authors:  Keisuke Uehara; Hayato Nakamura; Yasushi Yoshino; Atsuki Arimoto; Takehiro Kato; Yukihiro Yokoyama; Tomoki Ebata; Masato Nagino
Journal:  Surg Endosc       Date:  2015-03-21       Impact factor: 4.584

Review 3.  Postoperative health-related quality of life of patients with gynecological malignancy: a meta-analysis.

Authors:  Se-Ge Ma; Xue Deng; Lu Xing; Yan Huang
Journal:  Support Care Cancer       Date:  2021-02-17       Impact factor: 3.603

4.  Long-Term Survival, Prognostic Factors, and Quality of Life of Patients Undergoing Pelvic Exenteration for Cervical Cancer.

Authors:  Mihai Stanca; Dan Mihai Căpîlna; Mihai Emil Căpîlna
Journal:  Cancers (Basel)       Date:  2022-05-09       Impact factor: 6.575

5.  Total pelvic exenteration for gynecologic malignancies.

Authors:  Elisabeth J Diver; J Alejandro Rauh-Hain; Marcela G Del Carmen
Journal:  Int J Surg Oncol       Date:  2012-06-10

Review 6.  The role of imaging in pelvic exenteration for gynecological cancers.

Authors:  Pamela Ines Causa Andrieu; Sungmin Woo; Eric Rios-Doria; Yukio Sonoda; Soleen Ghafoor
Journal:  Br J Radiol       Date:  2021-05-07       Impact factor: 3.629

7.  Segmentary ureteral resection followed by ureteroneocystostomy associated with radical hysterectomy and partial cystectomy in a patient with bulky residual disease after chemoirradiation for invasive cervical cancer--a case report.

Authors:  N Bacalbaşa; I Bălescu
Journal:  J Med Life       Date:  2014 Oct-Dec

Review 8.  Emotional and sexual concerns in women undergoing pelvic surgery and associated treatment for gynecologic cancer.

Authors:  Cara Stabile; Abigail Gunn; Yukio Sonoda; Jeanne Carter
Journal:  Transl Androl Urol       Date:  2015-04

9.  Assessing Symptom Burden in Bladder Cancer: An Overview of Bladder Cancer Specific Health-Related Quality of Life Instruments.

Authors:  Bernard J Danna; Michael J Metcalfe; Erika L Wood; Jay B Shah
Journal:  Bladder Cancer       Date:  2016-07-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.